TCL Archive High-Dose Chemo, Stem Cell Transplant No Benefit For Node+ Breast Cancer January 25, 2008
TCL Archive A Message From NCI: “We Deeply Regret The Need To Eliminate This Program.” AP4 Applicants And Corporate Partners Spent Years, Money, Before NCI Pulled The Plug On Novel Public-Private Partnerships. Von Eschenbach Called AP4 “A New Paradigm” For Drug Development. NCI Executive Committee “Prioritized” Programs. April 21, 2006
TCL Archive House Appropriations Boosts NIH By $1 Billion In Draft Budget That Cuts Other HHS Programs September 30, 2011
TCL Archive New Toxicology Protocol Works, Predicts Safe starting Doses, Saves $1 Million June 25, 1982
TCL Archive FDA Approves Afinitor-Aromasin Regimen For Advanced HER2-Negative Breast Cancer July 27, 2012
